Showing results (661-670 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|May 3, 2014
Sustained CD4+ T cell-driven lymphopenia without a compensatory IL-7/IL-15 response among high-grade glioma patients treated with radiation and temozolomideSusannah Ellsworth, Ani Balmanoukian, Ferdynand Kos, et al.
Oncoimmunology|May 3, 2014
Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonistsNadia Luheshi, Gareth Davies, James Legg
Oncoimmunology|February 16, 2017
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patientsSylvie Rusakiewicz, Aurélie Perier, Michaela Semeraro, et al.
Oncoimmunology|February 16, 2017
CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancerShu Su, Zhengyun Zou, Fangjun Chen, et al.
Oncoimmunology|February 16, 2017
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancerRuea-Yea Huang, Ariel Francois, Aj Robert McGray, et al.
Oncoimmunology|February 16, 2017
Targeting Ewing sarcoma with activated and GD2-specific chimeric antigen receptor-engineered human NK cells induces upregulation of immune-inhibitory HLA-GSareetha Kailayangiri, Bianca Altvater, Christian Spurny, et al.
Oncoimmunology|February 16, 2017
Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasisIoanna Giopanou, Ioannis Lilis, Vassilios Papaleonidopoulos, et al.
Oncoimmunology|February 16, 2017
PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patientsDiane Goltz, Heidrun Gevensleben, Jörn Dietrich, et al.
Oncoimmunology|February 16, 2017
The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantationBertrand Routy, Caroline Letendre, David Enot, et al.
Oncoimmunology|February 16, 2017
Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cellsCarole Achard, Jean-Baptiste Guillerme, Daniela Bruni, et al.
Pageof 379